The need to develop and optimize PNP against human HNSCC, together with importance of advanced tools for improving PNP efficacy, prompted us to test the same Ad5‐PNP being used in human subjects against PDX tumors in mice. The gene discussed is PNP; the disease is head and neck squamous cell carcinoma.